Creatine monohydrate in resistant depression: a preliminary study
- PMID: 17988366
- DOI: 10.1111/j.1399-5618.2007.00532.x
Creatine monohydrate in resistant depression: a preliminary study
Abstract
Objectives: Creatine plays a pivotal role in brain energy homeostasis, and altered cerebral energy metabolism may be involved in the pathophysiology of depression. Oral creatine supplementation may modify brain high-energy phosphate metabolism in depressed subjects.
Methods: Eight unipolar and two bipolar patients with treatment-resistant depression were treated for four weeks with 3-5 g/day of creatine monohydrate in an open add-on design. Outcome measures were the Hamilton Depression Rating Scale, Hamilton Anxiety Scale, and Clinical Global Impression scores, recorded at baseline and at weeks 1, 2, 3 and 4.
Results: One patient improved considerably after one week and withdrew. Both bipolar patients developed hypomania/mania. For the remaining seven patients, all scale scores significantly improved. Adverse reactions were mild and transitory.
Conclusions: This small, preliminary, open study of creatine monohydrate suggests a beneficial effect of creatine augmentation in unipolar depression, but possible precipitation of a manic switch in bipolar depression.
Similar articles
-
Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).J Affect Disord. 2009 Nov;118(1-3):118-23. doi: 10.1016/j.jad.2009.02.007. Epub 2009 Mar 9. J Affect Disord. 2009. PMID: 19269690
-
Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.J Clin Psychopharmacol. 2008 Apr;28(2):171-81. doi: 10.1097/JCP.0b013e318166c4e6. J Clin Psychopharmacol. 2008. PMID: 18344727 Clinical Trial.
-
Response to ECT in bipolar I, bipolar II and unipolar depression.J Affect Disord. 2009 Nov;118(1-3):55-9. doi: 10.1016/j.jad.2009.01.014. Epub 2009 Feb 14. J Affect Disord. 2009. PMID: 19223079
-
Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.Bipolar Disord. 2008 Dec;10(8):957-68. doi: 10.1111/j.1399-5618.2008.00639.x. Bipolar Disord. 2008. PMID: 19594510 Review.
-
Hypomania and bipolar II disorder -- diagnostic validity and clinical utility.Psychiatr Hung. 2013;28(4):345-8. Psychiatr Hung. 2013. PMID: 24443571 Review. No abstract available.
Cited by
-
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine.Mol Psychiatry. 2023 Aug;28(8):3231-3242. doi: 10.1038/s41380-023-02134-8. Epub 2023 Jun 29. Mol Psychiatry. 2023. PMID: 37386057 Free PMC article. Review.
-
Role of Creatine Supplementation in Conditions Involving Mitochondrial Dysfunction: A Narrative Review.Nutrients. 2022 Jan 26;14(3):529. doi: 10.3390/nu14030529. Nutrients. 2022. PMID: 35276888 Free PMC article. Review.
-
Effects of Creatine Supplementation on Brain Function and Health.Nutrients. 2022 Feb 22;14(5):921. doi: 10.3390/nu14050921. Nutrients. 2022. PMID: 35267907 Free PMC article. Review.
-
Relationship between depression, prefrontal creatine and grey matter volume.J Psychopharmacol. 2021 Dec;35(12):1464-1472. doi: 10.1177/02698811211050550. Epub 2021 Oct 26. J Psychopharmacol. 2021. PMID: 34697970 Free PMC article.
-
The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment.Front Psychiatry. 2021 Jul 6;12:546801. doi: 10.3389/fpsyt.2021.546801. eCollection 2021. Front Psychiatry. 2021. PMID: 34295268 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical